Quantcast

Latest Prenatal diagnosis Stories

2009-07-07 13:15:00

A study of more than 64,000 pregnant women has found that miscarriage rates following amniocentesis and chorionic villus sampling (CVS) - two invasive procedures to detect chromosomal abnormalities and birth defects - were 1.4 per cent and 1.9 per cent, respectively.The research, published in the July issue of Ultrasound in Obstetrics and Gynecology, also found that the number of procedures carried out by a department had a significant effect on miscarriage rates.For example, the rates in...

2009-02-13 10:56:42

People facing possible genetic defects avoid pregnancy rather than undergo prenatal testing, a British researcher says. University of Exeter researcher Dr. Susan Kelly calls this deep-seated ambivalence about the options available to would-be parents as choosing not to choose and says it is not a simple rejection of medical intervention, opposition to abortion or affirmation of a positive parenting experience with a child already born with a genetic problem. It is also a desire for more...

2009-02-12 08:47:47

Parents of children with genetic conditions may avoid the need to choose whether to undergo pre-natal testing or to abort future pregnancies by simply avoiding subsequent pregnancy altogether, a study has found.Parents are 'choosing not to choose', researcher Dr Susan Kelly, who is based at the Egenis research centre at the University of Exeter, suggests, in a 'reflection of deep-seated ambivalence' about the options and the limitations of new reproductive technologies.According to 'Choosing...

2009-02-09 07:00:00

MENLO PARK, Calif., Feb. 9 /PRNewswire/ -- Artemis Health Inc., a privately-held company dedicated to the development of non-invasive prenatal diagnostic tests, today announced that Richard Rava, Ph.D., has joined Artemis Health in the newly created position of senior vice president of research and development. "Rich's depth and breadth of research, development and manufacturing experience, together with his proven track record in commercializing genetic analysis tools, makes him...

2009-02-05 03:00:00

MINEOLA, N.Y., Feb. 5 /PRNewswire/ -- Lenetix, Inc. today announced the launch of an Institutional Review Board (IRB)-approved screening study of an improved first and second trimester non-invasive fetal diagnostic test to detect Down syndrome. The Lenetix PloidYX(TM) maternal blood test promises to be the most accurate and comprehensive test yet developed for the detection of fetal aneuploidies, the presence of extra chromosomes, which cause Down syndrome (T-21) and other chromosomal...

2009-01-28 20:00:00

Lenetix Announces Successful Study of Improved Non-invasive Test Procedure MINEOLA, N.Y., Jan. 28 /PRNewswire/ -- Lenetix, Inc. today announced a significant step in the development of an improved first and second trimester non-invasive fetal chromosomal screening test to detect Down syndrome and other genetic fetal conditions. Lenetix presented preliminary study results at the 29th annual Society for Maternal-Fetal Medicine Conference in San Diego that indicate a potential breakthrough in...

2009-01-27 07:00:00

-- New Technology May Allow Development of Accurate Blood Test for Common Genetic Disorders Early in Pregnancy -- MENLO PARK, Calif., Jan. 27 /PRNewswire/ -- Artemis Health Inc., a privately-held company dedicated to the development of non-invasive prenatal diagnostic tests, today announced that it has acquired a co-exclusive worldwide license from Stanford University to develop cell-free fetal DNA prenatal diagnostic tests based on pioneering research from the lab of Stephen Quake, Ph.D.,...

4a5586123c8c9d0ee567b44255e821f71
2009-01-26 15:40:00

A new study by researchers at NYU Langone Medical Center found a high desire for additional genetic testing among consumers for life altering and threatening medical conditions including mental retardation, blindness, deafness, cancer, heart disease, dwarfism and shortened lifespan from death by 5 years of age. Consumers, however, are less interested in prenatal genetic testing for traits including tall stature, superior athletic ability and superior intelligence. "Our research has discovered...

2009-01-22 06:00:00

BEIJING, Jan. 22 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its Prenatal FISH Probe and Cervical Cancer FISH Probe from the State Food and Drug Administration (the "SFDA") in the People's Republic of China (the "PRC"). The Prenatal FISH Probe is a...

2008-12-23 15:36:00

Two stories of babies born in the unique Special Delivery Unit at The Children's Hospital of Philadelphia, true miracles on 34th Street PHILADELPHIA, Dec. 23 /PRNewswire-USNewswire/ -- Just 6 months after the Garbose Family Special Delivery Unit opened, more than 75 babies have been born and are sharing their first holiday season with their joyful families. Families from 13 states and at least two other countries have traveled to Children's Hospital for expert prenatal care, delivery and...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related